News

Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

2 years ago

EndoSound® Receives 510(k) Clearance for Breakthrough EVS® Innovation, a novel Endoscopic Ultrasound (EUS) technology

510(k) Clearance of first-of-kind Endoscopic Ultrasound (EUS) technology Paves the way for safer and more accessible medical care EndoSound will…

2 years ago

Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement

SAN DIEGO, CA / ACCESSWIRE / January 2, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified…

2 years ago

Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market

New Patents Demonstrate Uniqueness of the Closure Product DesignFORT MILL, SC / ACCESSWIRE / January 2, 2024 / Catheter Precision,…

2 years ago

Precipice Holdings Limited Acquires Common Shares of Nova Leap Health Corp.

HALIFAX, Nova Scotia, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Precipice Holdings Limited (“Precipice”) announces that it has acquired 118,200 common…

2 years ago

Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

-- PAS-004 is the first macrocyclic MEK inhibitor to enter human clinical trials -- -- Phase 1 dose escalation study…

2 years ago

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside Oak Ridge, TN,…

2 years ago

Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference

JUPITER, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology…

2 years ago

Coherus Announces U.S. Launch of LOQTORZI™

LOQTORZI™ (toripalimab-tpzi) LOQTORZI™ (toripalimab-tpzi) product image – Launch of LOQTORZI offers first and only FDA-approved treatment for NPC in all…

2 years ago